Trusted News Discovery Since 2008
{{/content}}
PGI Rohtak to start phase-2 human clinical trial of Bharat Biotech's Covid vaccine
Video Credit: HT Digital Content
Published on September 8, 2020 - Duration: 01:48s
PGI Rohtak to start phase-2 human clinical trial of Bharat Biotech's Covid vaccine
Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech's COVID-19 vaccine.
“We got permission from Bharat Biotech to start a phase-2 human clinical trial of their vaccine.
We've 300 volunteers, aged between 12 years and 65- years, out of which screening of 15 has been completed,” said Dr OP Kalra, vice-chancellor, PGI Rohtak.
Kalra also informed that in the phase-2 trail, they have recruited volunteers who have controlled diabetes and high blood pressure.
Watch the full video for more details.
You are here
Related videos from verified sources
Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister 02:29
Video credit: HT Digital Content - Published on September 30, 2020
Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials 02:37
Video credit: The Street - Published on September 30, 2020
Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP 01:36
Video credit: ANI - Published on September 30, 2020